COMMUNIQUÉS West-GlobeNewswire

Golden Leaf Holdings Announces Overwhelming Approval of Extraordinary Resolutions By Debenture Holders
22/08/2019
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis oil solutions company and dispensary operator built around recognized [...]
Immutep Granted European Patent for Eftilagimod Alpha in Cancer
22/08/2019
SYDNEY, Australia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Maverick Technology Solutions Announces the Launch of the Groundbreaking ROSINBOMB™ M-60 Extraction Press With Patent Pending Flow Channel Technology™
22/08/2019
Solventless, High-Quality, Large Volume Extract Production Now a Reality RENO, Nev., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), industry leading developer and manufacturer of the highly [...]
Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health System(s)
22/08/2019
MOORESTOWN, N.J., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a partnership between its [...]
Mustang Bio and St. Jude Children’s Research Hospital announce MB-107 lentiviral gene therapy for X-linked Severe Combined Immunodeficiency (XSCID) granted regenerative medicine advanced therapy (RMAT) designation from FDA
22/08/2019
RMAT designation follows positive Phase 1/2 clinical data published in the New England Journal of Medicine Designation to facilitate expedited development and review of MB-107 for XSCID NEW YORK and MEMPHIS, Tenn., Aug [...]
Inovalon to Present at the Citi 2019 Global Technology Conference
22/08/2019
BOWIE, Md., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer [...]
ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM®
22/08/2019
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention
22/08/2019
More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing SALT LAKE CITY, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and [...]
Clearside Biomedical Provides New Drug Application Update for XIPEREᵀᴹ (triamcinolone acetonide suprachoroidal injectable suspension)
22/08/2019
ALPHARETTA, Ga., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with [...]
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
22/08/2019
Lead candidate ONL1204 will advance to Phase I clinical study in retinal detachment in late 2019 ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel [...]
Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN
22/08/2019
FORT Study did not achieve its primary or secondary endpoints Company to host conference call and webcast today at 8:30 a.m. ET SAN DIEGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced [...]
So-Young to Report Second Quarter 2019 Financial Results on August 29, 2019
22/08/2019
BEIJING, Aug. 22, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
Philips signs agreement to create Taiwan’s first fully digitalized pathology department
22/08/2019
August 22, 2019 Philips IntelliSite Pathology Solution adopted by Taiwan’s leading academic medical and teaching center Taipei Veterans General Hospital Philips IntelliSite Pathology Solution cleared for routine primary [...]
JSC Olainfarm refinances its liabilities and receives financing for development projects
22/08/2019
JSC Olainfarm and financial partner the bank BlueOrange have agreed to refinance existing liabilities on improved terms, provide additional financing for the company's development projects and planned investment in [...]
Ambu A/S: Interim report for Q3 2018/19
22/08/2019
In Q3, Ambu has achieved solid organic growth of 10% and an EBIT margin before special items of 20.1%. The pipeline has been advanced, US approval of ENT scopes secured, and Ambu is on plan for future launch of the [...]
Arcoma AB: Kraftfull resultatförbättring och ökad omsättning
22/08/2019
FI NANS I ELLT SAMMANDRAG Andra kvartalet Nettoomsättning för kvartalet ökade med 10% till 33 879 (30 888) kSEK. EBITDA (rörelseresultat före avskrivningar) steg med 52% till 3 470 (2 277) kSEK Resultat efter skatt [...]
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
22/08/2019
Press Release Gosselies, Belgium, 22 August 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to [...]
Bone Therapeutics SA publiera ses résultats du premier semestre 2019 le 30 août 2019
22/08/2019
Communiqué de presse Gosselies, Belgique, le 22 août 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires [...]
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
22/08/2019
Company Announcement DARZALEX ® approved in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant in [...]

Pages